Chemomab Therapeutics (CMMB) EBIT (QoQ) (2018 - 2025)
Chemomab Therapeutics (CMMB) EBIT (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Chemomab Therapeutics | 13.53 Mn | 3.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35,920,142.37% |
| Dec 31, 2024 | 10,828,968.02% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -6.13% |
| Mar 31, 2024 | -91.75% |
| Dec 31, 2023 | 1,033.66% |
| Sep 30, 2023 | -47.88% |
| Jun 30, 2023 | -9.12% |
| Mar 31, 2023 | -82.34% |
| Dec 31, 2022 | 512.09% |
| Sep 30, 2022 | 19.99% |
| Jun 30, 2022 | 231.94% |
| Mar 31, 2022 | -116.47% |
| Dec 31, 2021 | 1,144.27% |
| Sep 30, 2021 | -7.15% |
| Jun 30, 2021 | -62.56% |
| Mar 31, 2021 | 72.23% |
| Dec 31, 2020 | -150.59% |
| Sep 30, 2020 | -126.55% |
| Jun 30, 2020 | 36.22% |